EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Impact of 16α-[18F]-fluoro-17β-Estradiol Positron Emission Tomography on the Staging and Management of Invasive Lobular Carcinoma of the Breast: A Case Series

Alexander E Crum, Alexandria Oliver, Marshall Harrell, Benjamin Facer, Therese Y Andraos, Rebekah Young, Jacob Eckstein, Emmanuel Appiah-Kubi, Bridget Oppong, Arya Roy, Margaret Gatti-Mays, Sachin R Jhawar und 1 weitere

Advances in Radiation Oncology · 2027-01 · 12 (1) · 102209

DOI: 10.1016/j.adro.2026.102209 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advances in Radiation Oncology, 2027-01. Verfasst von Alexander E Crum und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, The Ohio State University Wexner Medical Center, Columbus, Ohio. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: American College of Radiation Oncology.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Invasive lobular cancer (ILC) poses diagnostic challenges, often leading to upstaging at surgery and the potential for suboptimal initial management. 16α-[18F]-fluoro-17β-estradiol positron emission tomography (FES-PET) may enhance the initial staging and management of newly diagnosed locally advanced ILC. This case series explores FES-PET's potential role in optimizing the management of newly diagnosed locally advanced ILC. Methods and Materials: An institutional retrospective case series of 4 patients with ILC, newly diagnosed between April 2024 and April 2025, was conducted. Three patients underwent FES-PET, which altered or supported management, and 1 patient did not undergo FES-PET but was upstaged at the time of surgery. Data on patient demographics, standard-of-care, FES-PET imaging, and pre- and post-FES-PET management plans were collected.

Results

In case 1, who had 100% estrogen receptor (ER)-positivity, FES-PET detected supraclavicular nodal (maximum standardized uptake value [SUVmax] 3.3) and chest wall avidity (SUVmax 5.4) after neoadjuvant chemotherapy and multiple resections, prompting extended radiation volumes and a sequential boost to the supraclavicular nodes and chest wall. Case 2 had 95% ER-positive disease, and FES-PET detected osseous metastases (SUVmax 3.5), shifting to a metastatic management plan with systemic therapy. Case 3 had 100% ER-positive disease; FES-PET showed no metastatic disease after adjuvant chemotherapy for pT3N3a disease, prior to radiation. Case 4 was a patient with 100% ER-positive ILC, and with contemporary imaging alone was upstaged during surgery from cT2N1M0 to pT3N3a.

Conclusion

FES-PET results altered radiation dose and volumes, shifted treatment to systemic therapy, and supported the initial local treatment plan in cases 1 to 3. In case 4, baseline FES-PET may have identified more extensive disease before surgery, potentially reducing unexpected postoperative upstaging or subsequent treatment modification. FES-PET may help refine staging and treatment planning in selected patients with ER-positive locally advanced ILC; however, our study is limited by its retrospective design and limited number of patients. Prospective studies are warranted to determine whether upfront FES-PET changes management or improves clinical outcomes.

Autor:innen und Institutionen

  • Department of Radiation Oncology, The Ohio State University Wexner Medical Center, Columbus, Ohio.
  • Department of Radiology, The Ohio State University Wexner Medical Center, Columbus, Ohio.
  • Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio.
  • Department of Medical Oncology, The Ohio State University Wexner Medical Center, Columbus, Ohio.

Förderung

  • American College of Radiation Oncology

Zitieren

APA

Crum, A. E., Oliver, A., Harrell, M., Facer, B., Andraos, T. Y., Young, R., Eckstein, J., Appiah-Kubi, E., Oppong, B., Roy, A., Gatti-Mays, M., Jhawar, S. R., & Beyer, S. (2027). The Impact of 16α-[18F]-fluoro-17β-Estradiol Positron Emission Tomography on the Staging and Management of Invasive Lobular Carcinoma of the Breast: A Case Series. Advances in Radiation Oncology, 12(1), 102209. https://doi.org/10.1016/j.adro.2026.102209

Vancouver

Crum AE, Oliver A, Harrell M, Facer B, Andraos TY, Young R, et al. The Impact of 16α-[18F]-fluoro-17β-Estradiol Positron Emission Tomography on the Staging and Management of Invasive Lobular Carcinoma of the Breast: A Case Series. Advances in Radiation Oncology. 2027;12(1):102209. doi:10.1016/j.adro.2026.102209

BibTeX
@article{Crum2027,
  author = {Crum, Alexander E and Oliver, Alexandria and Harrell, Marshall and Facer, Benjamin and Andraos, Therese Y and Young, Rebekah and Eckstein, Jacob and Appiah-Kubi, Emmanuel and Oppong, Bridget and Roy, Arya and Gatti-Mays, Margaret and Jhawar, Sachin R and Beyer, Sasha},
  title = {The Impact of 16α-[18F]-fluoro-17β-Estradiol Positron Emission Tomography on the Staging and Management of Invasive Lobular Carcinoma of the Breast: A Case Series},
  journal = {Advances in Radiation Oncology},
  year = {2027},
  volume = {12},
  number = {1},
  pages = {102209},
  doi = {10.1016/j.adro.2026.102209}
}
Kostenlos starten →